Developing an integrated hearing aid system to assist parents of hearing impaired children during home based speech therapy (Biotechnology Research Assistance Council, Department of Science & Technology, Government of India)
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2019 - 2021
Project Lead
Dr. Ramesh A
Authors
Dr. Ramesh A
Project Status
completed
Project Type
ICMR